ARTG 341610Dialysate, haemodialysis
ARTG ID: 341610 · Nipro Australia Pty Ltd · Inspramed Medikal Sanayi ve Ticaret AS · Class IIb · Started August 17, 2020
Good Name: Nipro Australia Pty Ltd - Dialysate, haemodialysis
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 341610
- Start Date
- August 17, 2020
- Effective Date
- August 17, 2020
- Country
- Turkey
- Address
- Serest Bolge 8 Cad No 29 Melikgazi, Kayseri, Turkiye, 38070
Insprasol Haemodialysis Acid Concentrate is used for haemodialysis treatment by diluting suitably with basic bicarbonate concentrate and purified water. Diluted haemodialysis solution is used for replacing of electrolytes with toxic and liquid materials in blood via dialyser (semi-permeable membrane) without direct contact with blood. By this way, the electrolyte balance is provided.
Access comprehensive regulatory information for Dialysate, haemodialysis in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 341610 and sponsored by Nipro Australia Pty Ltd, manufactured by Inspramed Medikal Sanayi ve Ticaret AS in Turkey. The device registration started on August 17, 2020.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.